Immune to Cancer: The CRI Blog
-
Do Something Epic in 2015!
Meet a few of the riders who will join Team CRI in the 2015 Ride to Conquer…
-
Patient Story Featured at World Cancer Congress
The inspiring story of lung cancer survivor Pam G. put a human face on cancer immunotherapy.
-
Phase 3 Trial of Nivolumab Shows Survival Advantage in Lung Cancer
The results of a phase III trial are clear: the PD-1 checkpoint inhibitor nivolumab improves survival for…
-
Could That Steak Be Giving You Cancer?
A CRI postdoctoral fellow was part of the team investigating the relation of red meat to cancer…
-
The Marathon to End All Marathons: The Great Wall of China Marathon with Emma Saunders
With her family ravaged by cancer, Emma wanted to do something huge to help conquer the disease….
-
CRI’s 2014 Blog in Review: Top 10
We reflect on our favorite blog posts of 2014, including FDA approvals, editorials, conference coverage, history, awards,…
-
Smart Giving this Holiday Season
Before you make your donation to any organization, take some time to learn about their charity ratings.
-
New Cancer Immunotherapy Opdivo Approved by FDA
Just hours ago, the FDA approved Bristol-Myers Squibb's PD-1 drug for melanoma.
-
Faces of CRI: Introducing the People Who Make It Possible!
This holiday season, meet five Cancer Research Institute (CRI) staff members who want you to know why…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.